Ageing and Cancer Research & Treatment (ACRT) is pleased to announce the appointment of Professor Xingzhi Xu and Professor Baohua Liu from Shenzhen University as the new Editors-in-Chief. Their leadership marks a significant step forward in the journal’s mission to advance cutting-edge research in the intersecting fields of ageing, cancer biology, and translational medicine.
On June 17, 2025, the Editorial Office of Ageing and Cancer Research & Treatment (ACRT) had the honor of interviewing Professor Hans-Georg Rammensee, a distinguished Advisory Editor of the journal and a globally recognized expert in tumor immunology from the University of Tübingen, Germany.
On April 25, 2025, Ageing and Cancer Research & Treatment (ACRT) held its held its first webinar, titled "Immunosuppressive Tumor Microenvironment Mediated by Myeloid-Derived Suppressor Cells and their Targeting". The event drew over 13,000 international viewers, underscoring the growing interest in this critical area of cancer research.
On February 19, 2025, the Editorial Office of Ageing and Cancer Research & Treatment (ACRT) had the honor of interviewing Professor Per Thor Straten, Co-Editor-in-Chief of ACRT and a distinguished expert in tumor immunology at Herlev University Hospital in Copenhagen, Denmark. During the interview, Prof. Thor Straten shared valuable insights into his career, the future of T-cell-based immunotherapies, and his vision for the journal.
On February 11, 2025, the Editorial Office of Ageing and Cancer Research & Treatment (ACRT) had the privilege of interviewing Professor Guido Kroemer, a world-renowned expert in aging and cancer research from Université de Paris Cité, France.
My own research career began in the Department of Surgery, Cambridge University, UK in transplantation immunology, facing the problems of immunosuppression to prevent organ rejection and attempts to prevent this by tissue matching, pharmacological agents and immunological tolerance induction.
